Nerviano Medical Sciences will disclose data on novel anticancer molecules at the AACR Annual Meeting 2012.
The presentations include:
Magnaghi, P et al: “Identification of potent VCP/p97/CDC48 inhibitors with distinct biochemical mechanisms including a reversible, allosteric inhibitor that activates the unfolded protein response, induce autophagy and cancer cell death”. Oral presentation. Abstract Number: 2940 Presentation Time: Monday, Apr 02, 2012, 3:20 PM - 3:35 PM
Pulici, M et al: “Characterization of NMS-P285, a new highly selective and potent BRAF inhibitor”. Abstract Number: 3754. Presentation Time: Tuesday, Apr 03, 2012, 8:00 AM -12:00 PM
Montagnoli, A et al: “Characterization of new highly selective and potent PARP-1 inhibitors”. Abstract Number: 1775. Presentation Time: Monday, Apr 02, 2012, 8:00 AM -12:00 PM